All Stories

  1. B-cell editing: An emerging alternative of precision oncotherapy

    Article • January 2025, Elsevier

    Dr. Saptak Banerjee

  2. Neem Leaf Glycoprotein Disrupts Exhausted CD8+ T-Cell–Mediated Cancer Stem Cell Aggression

    Article • Molecular Cancer Research, May 2024, American Association for Cancer Research (AACR)

    Dr. Saptak Banerjee

  3. Synthesis, structural characterization, solid-state structures, and DNA binding studies of pseudo octahedral mercury(II)-N-heterocyclic carbene (NHC) complex

    Article • Inorganica Chimica Acta, May 2024, Elsevier

    Dr. Saptak Banerjee

  4. Neem leaf glycoprotein binding to Dectin-1 receptors on dendritic cell induces type-1 immunity through CARD9 mediated intracellular signal to NFκB

    Article • Cell Communication and Signaling, April 2024, Springer Science + Business Media

    Dr. Saptak Banerjee

  5. The immunomodulatory impact of naturally derived neem leaf glycoprotein on the initiation progression model of 4NQO induced murine oral carcinogenesis: a preclinical study

    Article • Frontiers in Immunology, March 2024, Frontiers

    Dr. Saptak Banerjee

  6. High monocytic MDSC signature predicts multi-drug resistance and cancer relapse in non-Hodgkin lymphoma patients treated with R-CHOP

    Article • Frontiers in Immunology, January 2024, Frontiers

    Dr. Saptak Banerjee

  7. Synthesis, structures, electrochemical characterizations, theoretical and anticancer studies of Pd(II)-, Pt(II)- NHC complexes

    Article • Inorganica Chimica Acta, January 2024, Elsevier

    Dr. Saptak Banerjee

  8. Cancer stem cell–immune cell crosstalk in breast tumor microenvironment: a determinant of therapeutic facet

    Article • Frontiers in Immunology, November 2023, Frontiers

    Dr. Saptak Banerjee

  9. Terminally Exhausted CD8+ T Cells Resistant to PD-1 Blockade Promote Generation and Maintenance of Aggressive Cancer Stem Cells

    Article • Cancer Research, March 2023, American Association for Cancer Research (AACR)

    Dr. Saptak Banerjee

  10. Tumor activated platelets induce vascular mimicry in mesenchymal stem cells and aid metastasis

    Article • Cytokine, October 2022, Elsevier

    Dr. Saptak Banerjee

  11. Lactic acid in alternative polarization and function of macrophages in tumor microenvironment

    Article • Human Immunology, May 2022, Elsevier

    Dr. Saptak Banerjee

  12. NLGP regulates RGS5‐TGFβ axis to promote pericyte‐dependent vascular normalization during restricted tumor growth

    Article • The FASEB Journal, April 2022, Wiley

    Dr. Saptak Banerjee

  13. RGS5–TGFβ–Smad2/3 axis switches pro- to anti-apoptotic signaling in tumor-residing pericytes, assisting tumor growth

    Article • Cell Death and Differentiation, May 2021, Springer Science + Business Media

    Dr. Saptak Banerjee

  14. Neem leaf glycoprotein salvages T cell functions from Myeloid-derived suppressor cells-suppression by altering IL-10/STAT3 axis in melanoma tumor microenvironment

    Article • Melanoma Research, February 2021, Wolters Kluwer Health

    Dr. Saptak Banerjee

  15. NLGP Attenuates Murine Melanoma and Carcinoma Metastasis by Modulating Cytotoxic CD8+ T Cells

    Article • Frontiers in Oncology, March 2020, Frontiers

    Dr. Saptak Banerjee

  16. Neem Leaf Glycoprotein Restrains VEGF Production by Direct Modulation of HIF1α-Linked Upstream and Downstream Cascades

    Article • Frontiers in Oncology, March 2020, Frontiers

    Dr. Saptak Banerjee

  17. Neem leaf glycoprotein regulates function of tumor associated M2 macrophages in hypoxic tumor core: Critical role of IL-10/STAT3 signaling

    Article • Molecular Immunology, December 2016, Elsevier

    Dr. Saptak Banerjee

  18. Neem leaf glycoprotein optimizes effector and regulatory functions within tumor microenvironment to intervene therapeutically the growth of B16 melanoma in C57BL/6 mice

    Article • Trials in Vaccinology, January 2015, Elsevier

    Dr. Saptak Banerjee

  19. Neem Leaf Glycoprotein Prophylaxis Transduces Immune Dependent Stop Signal for Tumor Angiogenic Switch within Tumor Microenvironment

    Article • PLOS One, November 2014, PLOS

    Dr. Saptak Banerjee

  20. A Monoclonal Antibody Against Neem Leaf Glycoprotein Recognizes Carcinoembryonic Antigen (CEA) and Restricts CEA Expressing Tumor Growth

    Article • Journal of Immunotherapy, October 2014, Wolters Kluwer Health

    Dr. Saptak Banerjee

  21. Supraglottic laryngeal tumor microenvironmental factors facilitate STAT3 dependent pro-tumorigenic switch in tumor associated macrophages to render utmost immune evasion

    Article • Immunology Letters, November 2013, Elsevier

    Dr. Saptak Banerjee

  22. Neem leaf glycoprotein is superior than Cisplatin and Sunitinib malate in restricting melanoma growth by normalization of tumor microenvironment

    Article • International Immunopharmacology, September 2013, Elsevier

    Dr. Saptak Banerjee

  23. Neem leaf glycoprotein overcomes indoleamine 2,3 dioxygenase mediated tolerance in dendritic cells by attenuating hyperactive regulatory T cells in cervical cancer stage IIIB patients

    Article • Human Immunology, August 2013, Elsevier

    Dr. Saptak Banerjee

  24. Tumor-Derived Vascular Pericytes Anergize Th Cells

    Article • The Journal of Immunology, July 2013, The American Association of Immunologists

    Dr. Saptak Banerjee

  25. Normalization of Tumor Microenvironment by Neem Leaf Glycoprotein Potentiates Effector T Cell Functions and Therapeutically Intervenes in the Growth of Mouse Sarcoma

    Article • PLOS One, June 2013, PLOS

    Dr. Saptak Banerjee

  26. Neem Leaf Glycoprotein Activates CD8+ T Cells to Promote Therapeutic Anti-Tumor Immunity Inhibiting the Growth of Mouse Sarcoma

    Article • PLOS One, January 2013, PLOS

    Dr. Saptak Banerjee

  27. Neem leaf glycoprotein is nontoxic to physiological functions of Swiss mice and Sprague Dawley rats: Histological, biochemical and immunological perspectives

    Article • International Immunopharmacology, January 2013, Elsevier

    Dr. Saptak Banerjee

  28. Neem leaf glycoprotein inhibits CD4+CD25+Foxp3+Tregs to restrict murine tumor growth

    Article • Immunotherapy, August 2011, Future Medicine

    Dr. Saptak Banerjee